Fatmata F Sesay1, Mary H Hodges2, Habib I Kamara2, Mohamed Turay2, Adam Wolfe3, Thomas T Samba4, Aminata S Koroma5, Wogba Kamara6, Amadou Fall7, Pamela Mitula7, Ishata Conteh7, Nuhu Maksha8, Amara Jambai9. 1. Helen Keller International, PO Box 369, Freetown, Sierra Leone fsesay@hki.org. 2. Helen Keller International, PO Box 369, Freetown, Sierra Leone. 3. Columbia University, Mailman School of Public Health, New York, NY USA. 4. Child Health and Expanded Program on Immunization, Ministry of Health and Sanitation, Freetown, Sierra Leone. 5. Nutrition Program, Ministry of Health and Sanitation Sierra Leone, Youyi Building Brookfields, Freetown Sierra Leone. 6. National HIV/AIDS Secretariat, Ministry of Health and Sanitation, Kingharman Road Freetown, Sierra Leone. 7. World Health Organization, Country Office, Sierra Leone and Inter Country Support Team for West Africa (IST-WA). 8. United Nations Children's Fund, Country Office, Sierra Leone. 9. Directorate of Disease Prevention and Control, Ministry of Health and Sanitation, Freetown, Sierra Leone.
Abstract
BACKGROUND: In May 2012, the twice-yearly Maternal and Child Health Week (MCHW) integrated vitamin A supplementation (VAS) and supplementary measles vaccination to reach all children 6-59 months in Sierra Leone. Following the MCHW, a post event coverage survey was conducted to validate VAS coverage and assess adverse events following immunization. METHODS: Using the WHO Expanded Program on Immunization sampling methodology, 30 clusters were randomly selected using population proportionate to size sampling. Fourteen caregivers of children 6-59 months were interviewed per cluster for precision of ±5%. Responses were collected via mobile phones using EpiSurveyor. RESULTS: Overall VAS and measles coverage was 91.9% and 91.6%, respectively, with no significant differences by age group, sex, religion or occupation. Major reasons given for not receiving VAS and measles vaccination were not knowing about the MCHW or being out of the area. Significantly more mild adverse events (fever, pain at injection site) were reported via the post event coverage survey (29.1%) than MCHW (0.01%) (p<0.0001). CONCLUSION: The MCHW reached >90% of children in Sierra Leone with equitable coverage. Increased reporting of mild adverse events during the survey may be attributed to delayed onset after measles vaccination and/or direct inquiry from enumerators. Even mild adverse events following immunization requires strengthened reporting during and after vaccination campaigns.
BACKGROUND: In May 2012, the twice-yearly Maternal and Child Health Week (MCHW) integrated vitamin A supplementation (VAS) and supplementary measles vaccination to reach all children 6-59 months in Sierra Leone. Following the MCHW, a post event coverage survey was conducted to validate VAS coverage and assess adverse events following immunization. METHODS: Using the WHO Expanded Program on Immunization sampling methodology, 30 clusters were randomly selected using population proportionate to size sampling. Fourteen caregivers of children 6-59 months were interviewed per cluster for precision of ±5%. Responses were collected via mobile phones using EpiSurveyor. RESULTS: Overall VAS and measles coverage was 91.9% and 91.6%, respectively, with no significant differences by age group, sex, religion or occupation. Major reasons given for not receiving VAS and measles vaccination were not knowing about the MCHW or being out of the area. Significantly more mild adverse events (fever, pain at injection site) were reported via the post event coverage survey (29.1%) than MCHW (0.01%) (p<0.0001). CONCLUSION: The MCHW reached >90% of children in Sierra Leone with equitable coverage. Increased reporting of mild adverse events during the survey may be attributed to delayed onset after measles vaccination and/or direct inquiry from enumerators. Even mild adverse events following immunization requires strengthened reporting during and after vaccination campaigns.
Authors: James P Wirth; Fabian Rohner; Bradley A Woodruff; Faraja Chiwile; Hannah Yankson; Aminata S Koroma; Feimata Russel; Fatmata Sesay; Elisa Dominguez; Nicolai Petry; Setareh Shahab-Ferdows; Mercedes de Onis; Mary H Hodges Journal: PLoS One Date: 2016-05-10 Impact factor: 3.240
Authors: Henry B Perry; Emma Sacks; Meike Schleiff; Richard Kumapley; Sundeep Gupta; Bahie M Rassekh; Paul A Freeman Journal: J Glob Health Date: 2017-06 Impact factor: 4.413
Authors: James P Wirth; Nicolai Petry; Sherry A Tanumihardjo; Lisa M Rogers; Erin McLean; Alison Greig; Greg S Garrett; Rolf D W Klemm; Fabian Rohner Journal: Nutrients Date: 2017-02-24 Impact factor: 5.717
Authors: Aminata S Koroma; Sulaiman G Conteh; Mariama Bah; Habib I Kamara; Mohamed Turay; Abdulai Kandeh; Anna Macauley; Henry Allieu; Anita A Kargbo; Mustapha Sonnie; Mary H Hodges Journal: Matern Child Nutr Date: 2020-07-27 Impact factor: 3.092
Authors: Aminata S Koroma; Habib I Kamara; Francis Moses; Mariama Bah; Mohamed Turay; Abdulai Kandeh; Shekuba Kandeh; Henry Allieu; Anita Kargbo; Anna MaCauley; Mary H Hodges; David Doledec Journal: Health Sci Rep Date: 2021-06-28